Venture CapitalRIA · CRD 321003SEC-RegisteredPrivate Fund Adviser

Updated:

Cadence Healthcare Ventures

Cadence Healthcare Ventures invests in early-stage healthcare startups from multiple offices.

Cadence Healthcare Ventures logo

Cadence Healthcare Ventures

Cadence is a MedTech-focused venture capital firm partnering with visionary teams to build acquisition-ready companies. From concept to commercialization, we engineer outcomes that matter - for patients, acquirers, and investors. We don’t just invest. We build. With two decades inside the innovation engines of healthcare, Founder & General Partner Chris Kaster has backed 60+ MedTech companies, led $1B+ in investments, and is trusted by founders, favored by strategics, and fluent in the nuance of MedTech exits. What sets Cadence apart: - Built for the buyout. Every company is engineered with acquirer priorities in mind. - Unrivaled access. Proprietary deal flow through board seats, operator networks, and deep strategic ties. - Hands-on partnership. Guiding teams through clinical, regulatory, and commercial milestones with precision. - AI & robotics focus. Backing the technologies that are redefining precision, efficiency, and outcomes. - Advisor edge. A best-in-class network of industry veterans, operators, and strategics fueling every decision.

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, United States

Additional offices

Beverly Hills · Morristown · Paris · San Francisco · Los Angeles · Ross · London

Principals

Chris Kaster

Founder and Managing Partner

Sector focus

Healthcare

Frequently asked questions

Who runs investment decisions at Cadence Healthcare Ventures?

Chris Kaster serves as Founder and Managing Partner.

Does Cadence Healthcare Ventures participate in fund commitments or only direct deals?

The firm focuses on direct investments in early-stage startups.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Venture Capital profiles